Contrasting SHL Telemedicine (NASDAQ:SHLT) and Oncology Institute (NASDAQ:TOI)
based on the strength of their profitability, analyst recommendations, earnings, risk, dividends, valuation and institutional ownership. Both companies are small-cap medical companies, but SHLT is the better stock.
Which is the best stock among these two small-cap medical firms? We will compare the two companies on the basis of their earnings, dividends and risk, as well as analyst recommendations, valuation, and profitability.
Insider and Institutional Ownership
Institutional investors own 9.3% of SHL Telemedicine's shares. Comparatively 33.9% Of Oncology Institute Shares are owned by Institutional Investors. Insiders own 13.1% of Oncology Institute's shares. MarketBeat has provided a list of the current ratings for SHL Telemedicine and Oncology Institute.
Sell Ratings
Hold Ratings
Buy Ratings
Strong Buy Ratings
Rating Score
SHL Telemedicine
0
0
0
0
N/A
Oncology Institute
0
0
2
0
3.00
Oncology Institute's consensus price target is $6.00. This represents a potential gain of 971.43%. Analysts clearly prefer Oncology Institute over SHL Telemedicine due to its higher potential upside.
Earnings and Valuation
This table compares SHL Telemedicine and Oncology Institute revenue, earnings per shares and valuation.
Gross Revenue
Price/Sales Ratio
Net Income
Earnings per Share
Price to Earnings Ratio
SHL Telemedicine
N/A
N/A
N/A
N/A
N/A
Oncology Institute
$242.48 Million
0.17
$150,000.00
($0.71)
-0.79
Oncology Institute generates higher revenues and earnings than SHL Telemedicine
Profitability
The table below compares SHL Telemedicine and Oncology Institute net margins with return on equity and returns on assets.
Net Margins
Return on Equity
Return on Assets
SHL Telemedicine
N/A
N/A
N/A
Oncology Institute
-17.41%
-26.61%
-12.99%
You can read more about it here:
Oncology Institute beats SHL Telemedicine in 5 out of 8 factors when comparing the two stocks.
SHL Telemedicine
Get Rating
)
SHL Telemedicine Ltd develops and markets personal telemedicine products with a particular focus on cardiovascular diseases. The company's solutions include CHF Monitoring Service, which helps patients with Congestive Heart Failure (CHF); COPD Monitoring Service, which helps patients with Chronic Obstructive pulmonary Disease (COPD); and Readmission Solutions to reduce heart-related readmissions. SHL Telemedicine Ltd. is located in Israel.
About Oncology Institute
Get Rating
)
The Oncology Institute, Inc., a company that provides medical oncology in the United States, offers a variety of services. The company is divided into three segments, including Dispensary Services, Patient Services and Clinical Trials & Other. The company offers physician services as well as in-house dispensary and clinical trial services. It also provides radiation, transfusions of blood products, and support for patients. The company offers and manages clinical trials such as managing clinical studies, palliative programs, stem cell transplants, and other services. The company serves both adult and senior cancer sufferers. MarketBeat.com offers a FREE daily email newsletter
.